Results 181 to 190 of about 131,739 (305)
Trends in Sedative-Hypnotic Prescription Among Insomnia Patients: A Nationwide Cohort Study From 2010 to 2022 in Korea. [PDF]
Shin J +7 more
europepmc +1 more source
Abstract Background and aims Ketamine assisted psychotherapy is a promising new treatment for alcohol use disorder (AUD). The psychoactive effects of repeated intravenous (IV) ketamine infusions in people with AUD and their mechanistic role in treating AUD are largely unknown.
Cassie Bloy +11 more
wiley +1 more source
Real-world data on the abuse potential of medications for the treatment of insomnia: a disproportionality analysis of the FAERS database. [PDF]
Saskin P +7 more
europepmc +1 more source
Abstract Background and aims There are currently no brief quantitative assessments that capture the drug patterns of people who engage in use of more than one drug on the same day or simultaneously. The current study examined the retest reliability, acceptability and feasibility of a new quantitative assessment to measure polysubstance use.
Amanda M. Bunting +7 more
wiley +1 more source
Risk of miscarriage after benzodiazepine use during pregnancy: updated systematic review and meta-analysis. [PDF]
Picot C +5 more
europepmc +1 more source
Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada
Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran +9 more
wiley +1 more source
Two Case Reports of Zolpidem Abuse and a Contemporary Review. [PDF]
Sun R, Zhu B, Wei J, Xiong N, Sun W.
europepmc +1 more source
Abstract Background and aims Evidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual‐level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing
Nathaniel Day +10 more
wiley +1 more source
A call for action: Closing the evidence gap in management of stimulant‐induced psychosis
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier +3 more
wiley +1 more source
Reducing Low-Value Delirium Care Using Behavioral Design in the Electronic Medical Record. [PDF]
Ji RZ +4 more
europepmc +1 more source

